Mirae Asset Global ETFs Holdings
URGN icon

Mirae Asset Global ETFs Holdings’s UroGen Pharma URGN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
18,866
+1,712
+10% +$34.3K ﹤0.01% 2086
2025
Q4 		$402K Buy
17,154
+137
+0.8% +$2.97K ﹤0.01% 1993
2025
Q3 		$339K Sell
17,017
-3,192
-16% -$57.3K ﹤0.01% 2048
2025
Q2 		$277K Sell
20,209
-3,111
-13% -$29.9K ﹤0.01% 2107
2025
Q1 		$258K Buy
23,320
+1,653
+8% +$17.6K ﹤0.01% 2188
2024
Q4 		$231K Buy
21,667
+969
+5% +$11.6K ﹤0.01% 2317
2024
Q3 		$263K Buy
20,698
+6,055
+41% +$89.9K ﹤0.01% 2230
2024
Q2 		$246K Buy
+14,643
New +$208K ﹤0.01% 2151

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return